Purpose
The Parker Institute for Cancer Immunotherapy (PICI) @ Stanford Medicine Bedside to Bench Grant Program supports early stage projects that will enhance interdisciplinary basic and translational research among the Stanford scientific community in Cancer Immunotherapy. The PICI Bedside to Bench Grant will support collaborations between basic scientists and clinical researchers that lead to fundamental discoveries and advance the field of cancer immunotherapy. These awards are targeted to faculty with early-stage, high-risk ideas that would not be funded by raditional sources. We are particularly interested in the following areas of study: T-Cell Therapies, Checkpoint Non-Responders, Antigen Discovery and the Tumor Microenvironment.
Funding Amount: Awards will be funded for two years, with an earliest start date of January 1st, 2019. Awards up to $150,000 direct costs ($75,000 per year, with 15% IDC to be added for a total of $86,250 per year.)
Eligibility: Refer to the SCI Funding Opportunity website for ALL eligibility requirements.
Timeline: Letter of intent (LOI) internal deadline: June 15, 2018, 5 pm
Additional information:
SCI Funding Opportunity website